Category Archive: 3) Swiss Markets and News
Swiss stock market rally loses momentum
The Swiss Market Index and global stock markets failed to extend last week’s rally after the Federal Reserve and Bank of Japan left rates unchanged and gave mixed messages about the global economic outlook.
Read More »
Read More »
UBS beats profit estimates as CEO pushes ahead with cost cuts
UBS Group AG beat analysts’ second-quarter profit estimates and said it’s on track to cut costs by 2.1 billion Swiss francs ($2.2 billion) through 2017, with Chief Executive Officer Sergio Ermotti struggling wi...
Read More »
Read More »
Credit Suisse’s turnaround is working, but vulnerable
Brought to you by Investec Switzerland. Just a month ago, Credit Suisse CEO Tidjane Thiam and Deutsche Bank CEO John Cryan risked, as one hedge fund manager put it, becoming the dead men walking of European banking as they struggled to shore up their...
Read More »
Read More »
Sergio Ermotti, UBS-CEO
Trotz überraschend gutem Quartalsergebnis dürfte die UBS ihre Dividende für 2016 nicht erhöhen, wie CEO Sergio Ermotti im Interview sagt. Er äussert sich zudem zur Korruptionsaffäre in Singapur.
Read More »
Read More »
What’s the policeman doing with that baguette?
Police officers are taking part in the European biennial of contemporary art, “Manifesta”, in Zurich: but not in their normal roles. They are actors in a social experiment. (SRF/swissinfo.ch) — swissinfo.ch is the international branch of the Swiss Broadcasting Corporation (SBC). Its role is to report on Switzerland and to provide a Swiss perspective on …
Read More »
Read More »
Maps Maponyane takes #Reserved4Me winner for shopping spree
Maps Maponyane, Investec’s brand ambassador, recently took the #Reserved4Me competition winner, Tebogo Rammutla, for a personal styling session. Here are the highlights of the day.
Read More »
Read More »
George Friedman: The Turkey Coup Dashes the US’ Hopes
George Friedman writes the free weekly column “This Week in Geopolitics” for Mauldin Economics. Subscribe here: http://goo.gl/vhvxME. Each week, you’ll receive an in-depth view of the forces driving events and investors in the next year, decade, or even a century from now.
Read More »
Read More »
Swiss markets fluctuate on earnings data
The Swiss Market Index is set to finish the week slightly higher as investors digest second quarter earnings reports and central bank policy announcements.
Read More »
Read More »
Roche CEO worried about U.K. drug research following Brexit
The U.K.’s decision to leave the European Union poses a threat to research and development in the pharmaceutical industry, Roche Holding AG Chief Executive Officer Severin Schwan said. A departure would mean the country would have to set up its own system for approving drugs for sale, a job now done for bloc members by the European Medicines Agency.
Read More »
Read More »
Börsen-Talk vom 22. Juli 2016
Wie sieht die Zwischenbilanz der Zahlensaison an der Schweizer Börse aus? Können Anleger mit weiteren Kursgewinnen rechnen? Aktien-Experte Thomas Germann von WMPartners gibt im Börsen-Talk Auskunft.
Read More »
Read More »
Jean-Paul Clozel, CEO Actelion
Nach einem erfolgreichen ersten Halbjahr erwartet Actelion-Chef Jean-Paul Clozel eine weitere Steigerung der Aktie. Optimistisch stimmt ihn die Markteinführung zweier wichtiger Medikamente.
Read More »
Read More »
Joe Root Masterclass – Trigger Movements
Joe Root discusses his trigger movements in the latest masterclass with ‘The Analyst’ Simon Hughes.
Read More »
Read More »
George Friedman: Terrorism Fuels Nationalism and Deglobalization of the World
George Friedman writes the free weekly column “This Week in Geopolitics” for Mauldin Economics. Subscribe here: http://goo.gl/fz8LE2. Each week you’ll receive an in-depth view of the forces driving events and investors in the next year, decade, or even a century from now.
Read More »
Read More »
Givaudan profit beats estimates on U.S. fragrance demand
Givaudan SA, the world’s largest flavors and fragrance company, reported first-half profit that beat analyst estimates on increased demand for perfumes. Earnings before interest, taxes, depreciation and amortization rose 13 percent to 638 million francs ($649 million), the Vernier, Switzerland-based company said in a statement on Monday. Analysts had predicted 576 million francs. Sales gained 6.2 percent on a like-for-like basis to 2.33 billion...
Read More »
Read More »
Novartis says profit may drop
Novartis AG said profit may fall this year as the Swiss drugmaker increases spending on the heart medicine Entresto and faces declining sales of its best-selling cancer treatment Gleevec. Core operating income will either be about the same as 2015 or decline by a percentage in the low single digits at constant exchange rates, Novartis said Tuesday in a statement. Sales will show little change.
Read More »
Read More »
Swiss participation in EU science projects at risk
Swiss scientists are worried the Brexit vote will impact their access to the EU research programme Horizon 2020. (SRF/swissinfo.ch) — swissinfo.ch is the international branch of the Swiss Broadcasting Corporation (SBC). Its role is to report on Switzerland and to provide a Swiss perspective on international events. For more articles, interviews and videos visit swissinfo.ch …
Read More »
Read More »